Ceptaris Therapeutics
Pharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides.
Launch date
Employees
Market cap
-
Enterprise valuation
$250m (Public information from Jul 2013)
Malvern Iowa (HQ)
Authorizing premium user...